Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nick

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancerRui Wang, Rebecca L Stone, Jason T Kaelber, et al.
Gynecologic Oncology|December 4, 2012
Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignanciesKathleen M Schmeler, Ginger L Wilson, Katherine Cain, et al.
Gynecologic Oncology|December 4, 2012
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancerCristina Ivan, Wei Hu, Justin Bottsford-Miller, et al.
Obstetrics and Gynecology|August 11, 2018
Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian CancerNicole D Fleming, Alpa M Nick, Robert L Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2011
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancerAdam D Steg, Ashwini A Katre, Blake Goodman, et al.
Gynecologic Oncology|March 13, 2016
Characteristics of 10-year survivors of high-grade serous ovarian carcinomaFanny Dao, Brooke A Schlappe, Jill Tseng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Estrous cycle modulates ovarian carcinoma growthGuillermo N Armaiz-Pena, Lingegowda S Mangala, Whitney A Spannuth, et al.
Cancer|August 25, 2015
Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancerJack L Watkins, Premal H Thaker, Alpa M Nick, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancerCharles N Landen, Tae-Jin Kim, Yvonne G Lin, et al.
Cell Reports|January 26, 2022
Endothelial p130cas confers resistance to anti-angiogenesis therapyYunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Electron cryotomography reveals ultrastructure alterations in platelets from patients with ovarian cancerRui Wang, Rebecca L Stone, Jason T Kaelber, et al.
Gynecologic Oncology|December 4, 2012
Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignanciesKathleen M Schmeler, Ginger L Wilson, Katherine Cain, et al.
Gynecologic Oncology|December 4, 2012
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancerCristina Ivan, Wei Hu, Justin Bottsford-Miller, et al.
Obstetrics and Gynecology|August 11, 2018
Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian CancerNicole D Fleming, Alpa M Nick, Robert L Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2011
Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancerAdam D Steg, Ashwini A Katre, Blake Goodman, et al.
Gynecologic Oncology|March 13, 2016
Characteristics of 10-year survivors of high-grade serous ovarian carcinomaFanny Dao, Brooke A Schlappe, Jill Tseng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Estrous cycle modulates ovarian carcinoma growthGuillermo N Armaiz-Pena, Lingegowda S Mangala, Whitney A Spannuth, et al.
Cancer|August 25, 2015
Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancerJack L Watkins, Premal H Thaker, Alpa M Nick, et al.
Neoplasia (New York, N.Y.)|October 28, 2008
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancerCharles N Landen, Tae-Jin Kim, Yvonne G Lin, et al.
Cell Reports|January 26, 2022
Endothelial p130cas confers resistance to anti-angiogenesis therapyYunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, et al.
Pageof 16